SARS-CoV-2-specific humoral and cellular immune responses to BNT162b2 vaccine in Fibrodysplasia ossificans progressiva patients.
Front Immunol. 2022 Nov 9;13:1017232. doi: 10.3389/fimmu.2022.1017232. eCollection 2022.
Front Immunol. 2022.
PMID: 36439163
Free PMC article.